Drawing for LEUPONE

USPTO serial 79438194

LEUPONE

Reviewed by CopyMark Law Group

Reg. 8397315Status 700Registered
Filing date
Status date
Registration date
Aug 18, 2026
Examiner
MORENO, PAUL A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LEUPONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; allergy medications; biological preparations for medical or veterinary purposes for the treatment of central precocious puberty, endometriosis, uterine fibroids, prostate cancer and breast cancer; drugs for medical purposes for the treatment of central precocious puberty, endometriosis, uterine fibroids, prostate cancer and breast cancer; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treatment of respiratory organsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 18, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 30, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 13, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2026RFNTREFUSAL PROCESSED BY IB—
Mar 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 6, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 5, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 30, 2026DOCKASSIGNED TO EXAMINER—
Dec 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance